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Abstract
Purpose Vitrification technology presents new opportuni-
ties for preservation of embryo derived stem cells without
first establishing a viable ESC line. This study tests the
feasibility of cryopreserving ICM cells using vitrification.
Materials and Methods ICMs from mouse embryos were
isolated and vitrified in HSV straws or on cryoloops. Upon
warming, the vitrified ICMs were cultured and observed for
attachment and morphology. Colonies were passaged every
3–6 days. ICMs and ICM-derived ESC colonies were tested
for expression of stem cell specific markers.
Results ICMs vitrified on both the cryoloop and the HSV
straw had high survival rates. ICM derived ESCs remained
undifferentiated for several passages and demonstrated
expression of typical stem cell markers; SSEA-1, Sox-2,
Oct 4 and alkaline phosphatase.
Conclusion This is the first report on successful vitrifica-
tion of isolated ICMs and the subsequent derivation of ESC
colonies. Vitrification of isolated ICMs is a novel approach
for preservation of the “stem cell source” material.
Keywords Blastocyst.Cryopreservation.Human
embryonic stem cells.Inner cell mass.Vitrification
Introduction
Embryonic stem cell (ESC) lines are derived from the inner
cell mass (ICM) of blastocysts, and the defining feature of
these cells is their ability to differentiate into a variety of
cell types that encompass all three embryonic germ layers
[1]. Pluripotent cell lines were first generated from mouse
blastocysts in 1981 [2]. Thomson and colleagues subse-
quently demonstrated successful derivation of embryonic
stem cells from human blastocysts [3]. Embryonic stem
cells, particularly human stem cells hold tremendous
potential in the field of regenerative medicine, in addition
to being a useful tool in basic scientific research and for
pharmacological and cytotoxicity screening [4, 5].
Methods for efficient and reliable preservation of
embryonic stem cells are necessary to preserve these
pluripotent cells for therapeutic and experimental use. The
traditional method for embryonic stem cell cryopreservation
has been slow cooling at rates of approximately −1°C per
minute [reviewed in [6]]. Recently, cryopreservation by
vitrification has received much attention. This technique
has been successfully applied to the cryopreservation of
embryos at a variety of stages [7–12] as well as oocytes
[13–15]. Vitrification involves ultra-rapid cooling of the
cell at rates as high as −20,000°C/min and the use of high
concentrations of cryoprotectant agents (CPA). To achieve
these high cooling rates the cell is frozen in miniscule
volumes of fluid in vessels that allow almost instantaneous
cooling to −196°C. Vitrification protocols have also been
successfully used for cryopreservation of human embryonic
stem cell lines [16, 17]. Numerous publications suggest that
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To date there have been no reports on the cryopreserva-
tion of ICM cells extracted from the blastocyst stage
embryo. Preservation of isolated embryo-derived stem cells
without first establishing a viable ES cell line offers a new
avenue for banking the stem cell source material. The small
number of cells in the ICM of Day 5 or Day 6 blastocysts
poses a special challenge during the cryopreservation
process. In this investigation we explore the feasibility of
ICM vitrification and subsequent establishment of ESC-like
colonies. ICM isolation methodology and its influence on
cryosurvival and subsequent retention of ES phenotype
were looked at.
Materials and methods
ICM isolation
Mouse one-cell zygotes (Charles River Laboratory;
Wilmington, MA) were used for all ICM isolation
experiments. The zygotes were thawed as per manufac-
turer’s instructions and cultured overnight in Global
Blastocyst medium (LifeGlobal; Guilford, CT, USA)
supplemented with 10% serum protein substitute (SPS,
Cooper/Sage; Pasadena, CA, USA). Embryos were
cultured at 37°C with 6% CO2 in air until Day 6.
ICMs from mouse embryos were isolated by immuno-
surgery [21], micro-dissection [22] or laser with micro-
dissection [23]. Zonae were removed from any unhatched
blastocysts using acid tyrodes solution. For immunosurgical
isolation, zona free blastocysts were incubated with 20% rat
anti-mouse serum for 1 h followed by 1 h incubation with
20% guinea pig complement. Lysed trophectodermal cells
were removed from ICMs by repeated pipetting with finely
drawn glass micropipettes. For both of the micro-dissection
techniques, zona-free blastocysts were first plated and
allowed to attach to the dish. After 48 h, the ICM
outgrowth was either micro- dissected free from surround-
ing trophectodermal cells or treated first with laser to
destroy any residual trophectoderm cells before micro-
dissection. Isolated ICMs were either cultured as fresh
controls or cryopreserved by vitrification.
ICM vitrification/warming
Vitrification of isolated ICMs was carried out using a two
step equilibration protocol: (1) 7.5% DMSO/7.5% ethylene
glycol (EG) for 2 min, (2) 15% DMSO/15% EG +10 μg/ml
Ficoll +0.65 mol/L sucrose for 45 s. The basal medium
used to constitute vitrification solutions was Global Blast
medium with 20% SPS. After the final equilibration step,
individual ICMs were loaded on to the vitrification carrier
and immersed in liquid nitrogen (LN2). In this study we
tested two different carrier systems; the cryoloop (Hampton
Research; Laguna, CA, USA) and the HSV straw (Mid-
Atlantic Diagnostics; Laurrel, NJ, USA). The cryoloop is a
microscopic nylon loop measuring ~1.0 mm in diameter.
For cryoloop vitrification, the ICM was loaded on to a thin
film of fluid applied to the loop, before plunging into a vial
containing LN2. The HSV straw consists of a capillary tube
with a cut out region, creating a narrow gutter and an outer
straw. The ICM was loaded on to the gutter, towards the
open edge. The outer straw was then drawn over it and
sealed to create a closed system. The entire unit was then
stored in LN2.
Warming of vitrified embryos was performed at 37°C.
The cryoloop or HSV straw was immersed directly in basal
culture medium containing 0.25 M sucrose. The ICM cells
displaced from the carriers were readily visualized using the
dissecting scope. After 2 min, recovered ICMs were moved
to the second solution containing 0.125 M sucrose for
3 min and then placed in culture.
ICM culture
Embryonic stem cell medium (ESC-sure DMEM; Applied
Stem Cell, Sunnyvale, CA, USA) supplemented with 20%
FBS, 200 mM non-essential amino acids, 100 U/ml
penicillin, 10 μg/ml streptomycin, 100 mM sodium
pyruvate and ß mercaptoethanol and 10 ng/ml of mouse
leukemia inhibitory factor (LIF; Chemicon; Temecula, CA,
USA) was used for culture of ICMs. ICM-derived ES cells
were cultivated on inactivated mouse embryonic feeder
layers (MEF). MEF cells were purchased (Applied Stem
Cell; Sunnyvale, CA, USA) and prepared as per manufac-
turer’s instructions. Alternatively, ICMs were grown with-
out feeder cells on 0.1% gelatin coated eight or 16 well
chamber slides with 25% MEF conditioned medium/75%
ESC complete medium. Cultures were monitored for
attachment and morphology. Within 2–3 days of seeding,
dome-like colonies developed. These cell clumps were
individually picked off of the culture surface and
disaggregated by treatment with trypsin: EDTA solution
for 3–5 min at room temperature. Dissociated cells were
re-seeded in to new dishes. Colonies were passaged
every 3–6 days, depending on colony growth. Culture
medium was exchanged every 48 h.
Stem cell characterization
ICMs and ICM-derived ESC colonies were tested during
the culture interval for expression of stem cell specific
markers; SSEA-1, Oct-4 and SOX-2 and alkaline phospa-
tase(AP) activity using the mouse ES/iPS cell characteriza-
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fixation and permeabilization was carried out using kit
reagents as per manufacturer’s instructions. After blocking,
cells were incubated with primary antibody against SSEA-
1, Sox-2 or Oct-4 overnight at 4°C. Cells were subse-
quently washed twice with PBS and incubated with
corresponding secondary antibodies conjugated with
Alexa Fluor 594 for 1 h at room temperature. Cell nuclei
were counterstained with DAPI for 10 min. Samples were
then washed and mounted on slides for further analysis.
Immunoflourescent staining was visualized using confocal
laser microscopy and optical sectioning with image
analysis software. Alkaline phospatase (AP) staining was
performed by incubating fixed cells with AP test solution
(provided in kit) for 2 h at room temperature. AP activity
was detected by light microscopy with phase-contrast
optics. AP positive cells from ICMs and ICM-derived
colonies stained dark navy blue.
Data analysis
The main outcome parameters measured were ICM survival,
recovery and ability to attach within 24 h of warming.
Differences between carriers were analyzed using Fishers
exact test. P values of <0.05 were considered significant.
Results
Isolated ICMs were easily vitrified using a two step
ethylene-glycol/DMSO protocol. The post-warming survival
rate was 100% (78/78). After plating, 95% (74/78) of ICMs
were able to attach to MEF feeder layers and proliferate in
culture. This was similar to the 95% attachment rate
observed with non-vitrified control ICMs after 24 h of
culture. Cryopreserved ICMs exhibited similar proliferation
patterns as fresh control ICM’s and could be passaged and
expanded.
Figure 1 depicts the morphology of vitrified-warmed
ICMs and the rapid increase in ICM outgrowth within 72 h
of plating. Morphologically the cells displayed character-
istics typical of pluripotent stem cells [3, 16] i.e. high ratio
of nucleus to cytoplasm and prominent nucleoli. ICM
derived colonies were tight and compact with distinct
borders. Alkaline phosphatase activity was also high in the
ICM-derived cells, another indication of stem cell origin
(Fig. 1F). Immunocytochemical analysis further confirmed
that ICM-derived ES-like cells from both fresh and vitrified
ICMs expressed markers characteristic of pluripotent stem
cells. Colonies were positive for SSEA-1, Sox-2 and Oct-4
(Fig. 2).
Approximately 5–7 days after the first passage, numer-
ous ESC-like colonies could be seen. Colony diameter was
observed to increase during this culture interval. Diameters
ranged from 50–100 μm in small colonies, 120–160 μmi n
medium colonies and over >180 μm in the larger colonies.
Cultures were trypsinized and re-plated when most colonies
fell in the mid-size range. Colonies could be dissociated in
to individual cells and re-seeded on to fresh MEF feeder
layers. ESC-like colonies were once again established. To
date the embryonic stem cell characteristics and colony-
forming ability of the vitrified-warmed ICM cells have been
maintained through three passages and up to 16 days in
culture. We saw no indication of premature differentiation
in the vitrified-warmed ICMs during the 16 days of culture.
Oct-4 expression increased with time in culture (Fig. 2E).
Table 1 compares outcomes with the two vitrification
carriers. No statistical difference was found in survival,
recovery or plating efficiency between the two carriers.
Both carriers proved to be effective and efficient systems
for ICM vitrification. The one distinct advantage of the
HSV straw was that it allowed aseptic vitrification with no
direct contact between ICM cells and LN2. ICM-derived
ES cells from both carriers retained their pluripotency and
stem cell characteristics for the 16 day culture duration
tested.
Separation of the ICM from the whole blastocyst is an
important step if ICM banking is to be successfully applied.
To this end we tried three different techniques for ICM
isolation but none appeared to influence overall survival
after warming or subsequent retention of ES phenotype
during culture. Survival and attachment of cryopreserved
ICMs was 85% (6/7) with immunosurgically isolated ICMs,
as compared to 92% (47/51) and 100% (21/21) with the
micro-dissection or micro-dissection/laser ablation tech-
nique, respectively. The immunosurgical method involved
lysis of trophectodermal cells surrounding the ICM and
thus required more hands-on manipulation of the embryo,
as compared to the two micro-dissection methods. With the
two microdissection methods, the ICM cluster was distinct-
ly larger, owing to the additional growth time in vitro
before actual ICM isolation. We observed that laser ablation
decreased residual contamination of ICMs with trophecto-
dermal cells before vitrification. ICM-derived stem cell
populations were evident and enriched with each cell
passage, regardless of initial amount of trophectodermal
cells contamination.
Discussion
Establishment of stable pluripotent stem cell lines from
embryos is a fairly labor-intensive process, involving numer-
ous cell passages. The efficiency of stem cell derivation from
the ICM of human embryos is between 30% and 50%,
depending on characteristics of the ICM [24].
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preservation of the “stem cell source” material, without first
establishing an ESC line. This may be especially valuable
for human ESC banking, eliminating the ethical complica-
tions of viable human embryos being kept in long term
storage for future stem cell derivation. The current work
represents the first attempt to cryopreserve isolated ICMs.
T h ec r y o p r e s e r v a t i o no ft h es m a l ln u m b e ro fc e l l s
comprising the ICM is technically challenging. Current
studies with embryos indicate that cryopreservation by
vitrification may result in higher cell survival rates than
with traditional slow cooling [19, 20]. Reubinoff et al.
[16] successfully applied vitrification to human embryonic
c e l ll i n e sH E S 1a n dH E S 2i na no p e np u l l e ds t r a w .
Vitrification resulted in 100% recovery of ES clumps,
subsequent attachment and colony formation. With slow
cooling, they noted that only 70% of ES cell clumps were
recovered after thawing and only 16% attached. Moreover,
developing colonies were undersized and only a minority
retained their pluripotent stem cell characteristics. Higher
attachment and recovery rates after vitrification as com-
pared to slow cooling were also reported by Li et al. [18].
Richards et al. [17] also observed higher post-thaw ES cell
differentiation and cell death with the conventional slow
freezing method as compared to vitrification in either open
pulled straws or sealed straws [17]. These published data
provided the rationale for applying vitrification method-
ology to ICM cryopreservation. The scope of this
investigation was to demonstrate the feasibility of ICM
vitrification in a safe and effective manner and to provide
evidence that the pluripotency of ICM cells was retained
for several passages.
Vitrification requires the use of high concentrations of
CPAs and ultra-rapid reduction in temperature to minimize
the toxicity of cryoprotectant agents. To achieve this,
special vessels or carriers are used that permit loading of
cells in volumes of <2 ul. The type of carrier can affect the
rate of cooling. Direct exposure of the cellular material to
LN2 as with the cryoloop results in cooling rates of close
to −20,000°C/min [11]. In contrast, with closed sealed
systems like the HSV straw, no direct contact is made with
LN2 and the insulating effect of the outer sheath may
reduce the cooling rate. The current data however establish
that with either the open cryoloop or closed HSV carrier, a
sufficiently high rate of temperature reduction was achieved
to ensure ICM stem cell survival and capacity to propagate
as pluripotent stem cell colonies. Concerns about cross-
contamination in LN2 storage containers [25] may however
make the closed HSV system more practical for long term
storage of ICMs.
All of the ICMs in this investigation were isolated from
blastocysts derived from frozen one-cell mouse embryos.
The fact that ICMs from embryos that had already been
cryopreserved once could survive a second cryopreservaton
Fig. 1 ICMs were isolated from mouse blastocysts. (A) Fresh ICM
before vitrification. (B-E) Morphology of vitrified—warmed ICMs after
plating on MEF feeder layer. (B) 3 hours after warming (C) 24 hours
(D) 48 hours (E) 72 hours. (F) Dome-like ICM outgrowth staining
positive for alkaline phosphatase. Trophectodermal and MEF cells
adjacent to ICM were negative for AP
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technique. Warmed ICMs showed little indication of
cellular damage and had high plating efficiency. Regardless
of the initial method of ICM isolation, stem cell character-
istics were retained by ICMs through at least three cell
passages and 16 days of culture. Oct-4 is highly expressed
in ES cells, and its expression is down regulated when cells
differentiate [26]. Increased expression of this marker along
with continued expression of SSEA-1 and Sox 2 are all
indicative of ICM-derived cells generating pluripotent stem
cells in culture.
Stem cell research holds great promise for the treatment
of numerous diseases and for advancing the field of
regenerative medicine. The demand for human embryonic
stem cells is expected to increase as ES cells and derived
tissue are used in therapeutic trials. Currently from 64 ES
cell lines available from NIH registry, only one cell line, H1
has been approved for clinical trials [27]. Clearly, additional
therapeutic grade stem cell lines derived in xeno-free
culture systems and meeting stringent GMP standards will
ultimately be needed. The source material for deriving such
cell lines comes from embryos derived from in vitro
fertilization. Cryopreservaton and storage of embryonic
stem cells may be more socially acceptable than establish-
ing banks of embryos exclusively for the purpose of future
embryonic stem cell derivation. Currently, there are nearly
400,000 IVF-produced embryos in frozen storage in the
United States alone [28]. Most of these will be used to treat
Fig. 2 Expression and localization of stem cell specific markers in
vitrified-warmed ICMs after 48 hours in culture. ICMs were tested for
expression of SSEA-1, Sox-2 and Oct-4 using immunoflouresecent
staining. Cells were imaged using confocal laser microscopy. (A) ICM
stained with SSEA 1 (red signal) and DAPI (blue signal). Staining is
detected primarily on ICM cell surface. (B) Enlarged image of ICM
cells stained with SSEA-1. (C) Sox-2 staining (red), detected in both
nucleus and cytoplasm. (D) Oct-4 staining (red), mostly in the
nucleus. MEF and any residual trophectodermal cells were negative
for stem cell markers. (E) Oct-4 expression on Day 16 of culture
Table 1 Effect of carrier on ICM vitrification
Recovery Survival Attachment
Cryoloop(Open) 21/21 (100%) 21/21 (100%) 20/21 (95%)
HSV (Closed) 57/58 (98%) 57/57 (100%) 54/57 (95%)
*No significant differences were found between carriers for all
parameters (P>0.05)
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discarded. ICM banking is a novel approach to the problem
of storing stem cell source material of varying genotypes
without long term banking of the whole embryo and/or
months of cell passaging of each donated embryo to derive
a unique stem cell line. ICM karyotyping might also be
possible before ICM vitrification.
Studies are underway to further expand the ESC
colonies, derived from vitrified mouse ICMs to further
document pluripotent functionality and retention of stem
cell characteristics over extended in vitro culture intervals.
Further validation of the concept of ICM banking requires
the establishment of an ES cell line from a vitrified ICM
that is capable of differentiating into the three embryonic
germ cell lines both in vivo, after transplantation and in
vitro thru directed differentiation using defined culture
conditions. Mouse strain can affect the efficiency of
establishing ES cell lines from isolated ICMs [29]. The
strain used in this investigation is routinely used for IVF
quality control. Long term studies are needed to determine
its efficiency for establishing stable ES cell lines.
Conclusions
Our findings present a new approach to embryonic stem
cell banking. Expansion of this work to human embryos is
needed to determine if human ICMs are as easily vitrified
and expanded as those in the mouse model. Timing of ICM
isolation from human embryos can impact hESC derivation
[24]. Optimization and simplification of ICM isolation
protocols needs further investigation. Immunosurgical
isolation methods for human ICM are less desirable due
to the use of animal-derived reagents [27]. Laser ablation
combined with micro-dissection and improved culture
methodology for expansion of human ICM-derived stem
cells without exposure to animal feeder layers or sera are
still clearly needed to produce “clinical grade” stem cells
suitable for therapeutic applications.
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